En coup de sabre morphea and Parry-Romberg syndrome: A retrospective review of 54 patients

Journal of the American Academy of Dermatology

Volumn 56, Issue 2, 2007, Pages 257-263

  Tollefson, Megha M ^a   Witman, Patricia M ^a,b  

^a Departments of Pediatric and Adolescent Medicine   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; HYDROXYCHLOROQUINE; METHOTREXATE; STEROID; TETRACYCLINE;

ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HEMIFACIAL ATROPHY; HUMAN; LINEAR SCLERODERMA; MAJOR CLINICAL STUDY; MALE; MORPHEA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEIZURE; TERTIARY HEALTH CARE;

ADOLESCENT; ADULT; AGED; CHILD; DERMATOLOGIC AGENTS; DISEASE PROGRESSION; FACIAL HEMIATROPHY; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; RETROSPECTIVE STUDIES; SCLERODERMA, LOCALIZED; SEIZURES;

EID: 33846077009     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.10.959     Document Type: Article

References (33)

1. Peterson L.S., Nelson A.M., and Su W.P. Classification of morphea (localized scleroderma). Mayo Clin Proc 70 (1995) 1068-1076
2. Zulian F. Scleroderma in children. Pediatr Clin North Am 52 (2005) 521-545 vii
3. Stone J. Parry-Romberg syndrome: a global survey of 205 patients using the Internet. Neurology 61 (2003) 674-676
4. Blaszczyk M., Krolicki L., Krasu M., Glinska O., and Jablonska S. Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre. J Rheumatol 30 (2003) 1997-2004
5. Orozco-Covarrubias L., Guzman-Meza A., Ridaura-Sanz C., Carrasco Daza D., Sosa-de-Martinez C., and Ruiz-Maldonado R. Scleroderma 'en coup de sabre' and progressive facial hemiatrophy. Is it possible to differentiate them?. J Eur Acad Dermatol Venereol 16 (2002) 361-366
6. Lehman T.J. The Parry Romberg syndrome of progressive facial hemiatrophy and linear scleroderma en coup de sabre. Mistaken diagnosis or overlapping conditions?. J Rheumatol 19 (1992) 844-845
7. Sommer A., Gambichler T., Bacharach-Buhles M., von Rothenburg T., Altmeyer P., and Kreuter A. Clinical and serological characteristics of progressive facial hemiatrophy: a case series of 12 patients. J Am Acad Dermatol 54 (2006) 227-233
8. David J., Wilson J., and Woo P. Scleroderma 'en coup de sabre.'. Ann Rheum Dis 50 (1991) 260-262
9. Korkmaz C., Adapinar B., and Uysal S. Beneficial effect of immunosuppressive drugs on Parry-Romberg syndrome: a case report and review of the literature. South Med J 98 (2005) 940-942
10. Rai R., Handa S., Gupta S., and Kumar B. Bilateral en coup de saber-a rare entity. Pediatr Dermatol 17 (2000) 222-224
11. Unterberger I., Trinka E., Engelhardt K., Muigg A., Eller P., Wagner M., et al. Linear scleroderma "en coup de saber" coexisting with plaque-morphea: neuroradiological manifestation and response to corticosteroids. J Neurol Neurosurg Psychiatry 74 (2003) 661-664
12. Uziel Y., Feldman B.M., Krafchik B.R., Yeung R.S., and Laxer R.M. Methotrexate and corticosteroid therapy for pediatric localized scleroderma. J Pediatr 136 (2000) 91-95
13. Peterson L.S., Nelson A.M., Su W.P., Mason T., O'Fallon W.M., and Gabriel S.E. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. J Rheumatol 24 (1997) 73-80
14. Gambichler T., Kreuter A., Hoffmann K., Bechara F.G., Altmeyer P., and Jansen T. Bilateral linear scleroderma "en coup de saber" associated with facial atrophy and neurological complications. BMC Dermatol 1 (2001) 9
15. Dilley J.J., and Perry H.O. Bilateral linear scleroderma en coup de sabre. Arch Dermatol 97 (1968) 688-689
16. Falanga V., Medsger Jr. T.A., Reichlin M., and Rodnan G.P. Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities. Ann Intern Med 104 (1986) 849-857
17. Holland K.E., Steffes B., Nocton J.J., Schwabe M.J., Jacobson R.D., and Drolet B.A. Linear scleroderma en coup de sabre with associated neurologic abnormalities. Pediatrics 117 (2006) e132-e136
18. Zulian F., Athreya B.H., Laxer R., Nelson A.M., Feitosa de Olivera S.K., Punaro M.G., et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology (Oxf) 45 (2005) 614-620
19. Higashi Y., Kanekura T., Fukumaru K., and Kanzaki T. Scleroderma en coup de sabre with central nervous system involvement. J Dermatol 27 (2000) 486-488
20. Appenzeller S., Montenegro M.A., Dertkigil S.S., Sampaoio-Barros P.D., Marques-Neto J.F., Samara A.M., et al. Neuroimaging findings in scleroderma en coup de sabre. Neurology 62 (2004) 1585-1589
21. Gambichler T., Kreuter A., Rotterdam S., Altmeyer P., and Hoffmann K. Linear scleroderma 'en coup de sabre' treated with topical calcipotriol and cream psoralen plus ultraviolet A. J Eur Acad Dermatol Venereol 17 (2003) 601-602
22. Goldberg-Stern H., deGrauw T., Passo M., and Ball Jr. W.S. Parry-Romberg syndrome: follow-up imaging during suppressive therapy. Neuroradiology 39 (1997) 873-876
23. van Bergen B.H., van Dooren-Greebe R.J., Fiselier T.J., and Koopman R.J. [D-penicillamine in treatment of scleroderma "en coup de saber".]. Hautarzt 48 (1997) 42-44 German
24. Falanga V., and Medsger Jr. T.A. D-penicillamine in the treatment of localized scleroderma. Arch Dermatol 126 (1990) 609-612
25. Elst E.F., Van Suijlekom-Smit L.W., and Oranje A.P. Treatment of linear scleroderma with oral 1,25-dihydroxyvitamin D3 (calcitriol) in seven children. Pediatr Dermatol 16 (1999) 53-58
26. Cunningham B.B., Landells I.D., Langman C., Sailer D.E., and Paller A.S. Topical calcipotriene for morphea/linear scleroderma. J Am Acad Dermatol 39 (1998) 211-215
27. Hulshof M.M., Bouwes Bavinck J.N., Bergman W., Masclee A.A., Heickendorff L., Breedveld F.C., et al. Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma. J Am Acad Dermatol 43 (2000) 1017-1023
28. Sapadin A.N., and Fleischmajer R. Treatment of scleroderma. Arch Dermatol 138 (2002) 99-105
29. Weiss J.S. Antimalarial medications in dermatology. A review. Dermatol Clin 9 (1991) 377-385
30. Person J.R., and Su W.P. Subcutaneous morphoea: a clinical study of sixteen cases. Br J Dermatol 100 (1979) 371-380
31. Fitch P.G., Rettig P., Burnham J.M., Finkel T.H., Yan A.C., Akin E., et al. Treatment of pediatric localized scleroderma with methotrexate. J Rheumatol 33 (2006) 609-614
32. Seyger M.M., van den Hoogen F.H., de Boo T., and de Jong E.M. Low-dose methotrexate in the treatment of widespread morphea. J Am Acad Dermatol 39 (1998) 220-225
33. Kreuter A., Gambichler T., Breuckmann F., Rotterdam S., Freitag M., Stuecker M., et al. Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma. Arch Dermatol 141 (2005) 847-852